瑞舒伐他汀钙, HMG-CoA 还原酶抑制剂

CAS: 147098-20-2 货号: R408257 分子式: C22H27FN3O6S·1/2Ca 分子量: 500.57 EC号: 627-028-1 PubChem CID: 5282455
有货
级别和纯度: Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。 10mM in DMSO
储存条件
-80℃储存
运输条件
特低温运输
★
规格
库存
价格
数量
1ml
R408257-1ml
现货 Stock Image
¥289.90
请输入您要添加的产品数量

概述

Rosuvastatin Calcium是一种竞争性HMG-CoA还原酶抑制剂, with IC50为11 nM。A selective and competitive inhibitor of HMG-CoA reductase.

Information

Rosuvastatin Calcium (ZD4522) is a competitive inhibitor ofHMG-CoA reductasewithIC50of 11 nM in a cell-free assay.
In vitro

Rosuvastatin is relatively hydrophilic and is highly selective for hepatic cells; its uptake is mediated by the liver-specific organic anion transporter OATP-C. Rosuvastatin is a high-affinity substrate for OATP-C with apparent association constant of 8.5 μM. Rosuvastatin inhibits cholesterol biosynthesis in rat liver isolated hepatocytes with IC50 of 1.12 nM. Rosuvastatin causes approximately 10 times greater increase of mRNA of LDL receptors than pravastatin. Rosuvastatin (100 μM) decreases the extent of U937 adhesion to TNF-α-stimulated HUVEC. Rosuvastatin inhibits the expressions of ICAM-1, MCP-1, IL-8, IL-6, and COX-2 mRNA and protein levels through inhibition of c-Jun N-terminal kinase and nuclear factor-kB in endothelial cells.

In vivo

Rosuvastatin is efficient on reducing plasma liquids. Rosuvastatin (3 mg/kg) daily administration for 14 days decreases plasma cholesterol levels by 26% in male beagle dogs with normal cholesterol levels. In cynomolgus monkeys, Rosuvastatin decreases plasma cholesterol levels by 22% Rosuvastatin (20 mg/kg/day) administration for 2 weeks, significantly reduces very low-density lipoproteins (VLDL) in diabetes mellitus rats induced by Streptozocin. Rosuvastatin shows antiatherothromhotic effects in vivo. Rosuvastatin (1.25 mg/kg) significantly inhibits thrombin-induced transmigration of monocvtes across mesenteric venules via inhibition of the endothelial cell surface expression of P-selectin, and increases the basal rate of nitric oxide in aortic segments by 2-fold times. Rosuvastatin (20 mg/kg) inhibits ROS production, normalizes NO-dependent endothelial function and reduces platelet activation in diabetic rats induced by Streptozocin. Rosuvastatin displays cardioprotective effects in vivo. Rosuvastatin (80 mg) is shows to decrease infarct size and improve cardiac mechanical function after ischemia/reperfusion in animal model. The cardioprotective properties of Rosuvastatin may be due to the improvement of coronary blood flow, decrease in resistance of coronary arteries mediated by enhanced eNOS expression, and the subsequent increase in the production of vascular endothelial NO. Rosuvastatin (2.0 mg/kg) attenuates left ventricular hypertrophy produced by transaortic constriction in mice through regulation of Racl protein and NADPH oxidase activities.
Cell Data

cell lines:HL-60, U937, and NB-4 cells

Concentrations:

Incubation Time:

Powder Purity:≥99%

规格

英文别名
calcium (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethan-3-ylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate
规格或纯度
Moligand™, 10mM in DMSO
英文名称
Rosuvastatin (ZD4522) calcium
生化机理
瑞舒伐他汀钙片(ZD4522)是一种 HMG-CoA 还原酶竞争性抑制剂,在无细胞试验中的 IC50 值为 11 nM。
储存条件
-80℃储存
运输条件
特低温运输
作用类型
抑制剂
作用机制
HMG-CoA 还原酶抑制剂
名称和识别符
EC号
627-028-1
分子类型
小分子
Isomeric SMILES
CC(C1=NC(=NC(=C1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C2=CC=C(C=C2)F)N(S(=O)(=O)C)C)C.CC(C1=NC(=NC(=C1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C2=CC=C(C=C2)F)N(S(=O)(=O)C)C)C.[Ca+2]
PubChem CID
分子量
500.57

高级数据

化学和物理性质
溶解性
Solubility (25°C) In vitro Water: 5 mg/mL (38.11 mM); DMSO: Insoluble;  
比旋光度
-8° (C=1,CHCl3)
熔点
160 °C
安全和危险性(GHS)
象形图
GHS08,   GHS09
信号词
危险
危险声明

H410: 对水生生物毒性极大并具有长期持续影响

H372: 长期或反复接触会对器官造成损害

H360: 可能对生育能力或胎儿造成伤害

H350: 可能导致癌症

H370: 对器官造成损害

H362: 可能对母乳喂养的孩子造成伤害

预防措施声明

P273: 避免释放到环境中。

P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。

P321: 特殊处理(请参阅此标签上的...)。

P405: 密闭存放

P501: 将内容物/容器送到批准的废物处理厂处理

P264: 处理后要彻底洗手。

P260: 不要吸入灰尘/烟雾/气体/雾/蒸汽/喷雾。

P270: 使用本产品时,请勿进食、饮水或吸烟。

P391: 收集溢出物

P263: 避免在怀孕期间/哺乳期间接触。

P203: 使用前,获取、阅读并遵守所有安全说明。

P318: 如果暴露或担心,请就医。

P308+P316: 如果暴露或担心:立即寻求紧急医疗救助。

P319: 如果你感到不适,请寻求医疗帮助。

Merck Index
8270
质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
技术文档和文章
此产品的引用文献
溶液计算器